1. DOP39 Utilization and sustainability of biologics in UC - A nationwide study from the epi-IIRN. (27th May 2021) Authors: Atia, O; Yogev, D; Friss, C; Focht, G; Orlanski-Meyer, E; Magen Rimon, R; Ledderman, N; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Gabay, H; Nevo, D; Matz, E; Gorelik, Y; Chowers, Y; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP44 Long term outcomes of patients with untreated IBD - A population-based analysis from the epi-IIRN. (27th May 2021) Authors: Magen Rimon, R; Atia, O; Friss, C; Ledderman, N; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Gabay, C; Shaoul, R; Odes, S; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP46 Sustainability rate of immunomodulators monotherapy in patients with Crohn's Diseases: A population-based analysis from the epi-IIRN cohort. (27th May 2021) Authors: Atia, O; Friss, C; Mendelovici, A; Shteyer, E; Yogev, D; Ledderman, N; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Gabay, H; Nevo, D; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP72 The association of anti-tumor necrosis factor and thiopurine therapy with the risk of lymphoma among Inflammatory Bowel Disease patients: A nation-wide study from the epi-IIRN. (21st January 2022) Authors: Waterman, M; Lavi, I; Harel, S; Focht, G; Loewenberg Weisband, J; Greenfeld, S; Kariv, R; Ledderman, N; Matz, E; Keinan-Boker, L; Eizenstein, S; Dotan, I; Turner, D; Levi, Z Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP73 Antibiotic use differentially affects the risk of antidrug antibody formation during anti-TNFα therapy in Inflammatory Bowel Disease. (27th May 2021) Authors: Gorelik, Y; Freilich, S; Gerassy-Vainberg, S; Blatt, A; Pressman, S; Focht, G; Friss, C; Loewenberg Weisband, Y; Greenfeld, S; Kariv, R; Ledderman, N; Iris, D; Kashi, Y; Turner, D; Chowers, Y Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P269 Predicting IBD years before diagnosis using routine blood tests. (30th January 2023) Authors: Lev Zion, R; Dolev, A S; Greenfeld, S; Kariv, R; Ledderman, N; Matz, E; Dotan, I; Kopylov, U; Turner, D; Lerner, B Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P292 Complications in elderly-onset Inflammatory Bowel Diseases – A population-based study from the epidemiological database of the Israeli IBD Research Nucleus (Epi-IIRN). (30th January 2023) Authors: Ben Hur, D; Lebedenko, B; Issaschar, G; Moshe, R; Lujan, R; Focht, G; Loewenberg Weisband, Y; Kariv, R; Ledderman, N; Matz, E; Dotan, I; Turner, D; Pinto, G; Waterman, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P467 5-ASA is not superior to no-maintenance in patients with newly diagnosed Crohn's disease - a nationwide cohort from the epi-IIRN. (30th January 2023) Authors: Atia, O; Goren, I; Sharar Fischler, T; Loewenberg Weisband, Y; Greenfeld, S; Kariv, R; Ledderman, N; Matz, E; Magen Rimon, R; Dotan, I; Turner, D; Yanai, H Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P616 Sustainability of thiopurines monotherapy in ulcerative colitis: a nationwide analysis from the epi-IIRN cohort. (27th May 2021) Authors: Atia, O; Friss, C; Mendelovici, A; Shteyer, E; Orlanski-Meyer, E; Ledderman, N; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Gabay, H; Nevo, D; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P785 The prevalence of inflammatory bowel disease doubled in the last decade in Israel: an epiIIRN national population-based study. (25th January 2019) Authors: Friedman, M; Navon, D; Asayag, N; Focht, G; Brufman, I; Feldman, B; Cahan, A; Ledderman, N; Matz, E; Chowers, Y; Eliakim, R; Ben-Horin, S; Odes, S; Schwartz, D; Dotan, I; Israeli, E; Balicer, R D; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗